Envista Holdings Corp (NVST)

USD 15.23

(2.42%)

Operating Expenses Summary of Envista Holdings Corp

Envista Holdings Corp's latest annual operating expenses in 2023 was 1.15 Billion USD , down -0.42% from previous year.
Envista Holdings Corp's latest quarterly operating expenses in 2024 Q3 was 296.4 Million USD , down -8.41% from previous quarter.
Envista Holdings Corp reported a annual operating expenses of 1.15 Billion USD in annual operating expenses 2022, up 3.15% from previous year.
Envista Holdings Corp reported a annual operating expenses of 1.12 Billion USD in annual operating expenses 2021, down -0.4% from previous year.
Envista Holdings Corp reported a quarterly operating expenses of 323.6 Million USD for 2024 Q2, up 6.8% from previous quarter.
Envista Holdings Corp reported a quarterly operating expenses of 296.4 Million USD for 2024 Q3, down -8.41% from previous quarter.

Annual Operating Expenses Chart of Envista Holdings Corp (2023 - 2016)

Historical Annual Operating Expenses of Envista Holdings Corp (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	1.15 Billion USD	-0.42%
2022	1.15 Billion USD	3.15%
2021	1.12 Billion USD	-0.4%
2020	1.12 Billion USD	-8.97%
2019	1.23 Billion USD	-5.2%
2018	1.3 Billion USD	5.57%
2017	1.23 Billion USD	3.03%
2016	1.19 Billion USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	303 Million USD	8.06%
2024 Q2	323.6 Million USD	6.8%
2024 Q3	296.4 Million USD	-8.41%
2023 FY	1.15 Billion USD	-0.42%
2023 Q3	280 Million USD	-6.57%
2023 Q2	299.7 Million USD	3.13%
2023 Q1	290.6 Million USD	4.46%
2023 Q4	280.4 Million USD	0.14%
2022 FY	1.15 Billion USD	3.15%
2022 Q4	278.2 Million USD	-4.14%
2022 Q3	290.2 Million USD	-2.19%
2022 Q2	296.7 Million USD	4.99%
2022 Q1	282.6 Million USD	-4.88%
2021 Q2	313.4 Million USD	8.44%
2021 FY	1.12 Billion USD	-0.4%
2021 Q3	274.6 Million USD	-12.38%
2021 Q1	289 Million USD	-0.93%
2021 Q4	297.1 Million USD	8.19%
2020 Q3	271.3 Million USD	4.99%
2020 Q4	291.7 Million USD	7.52%
2020 FY	1.12 Billion USD	-8.97%
2020 Q1	303.4 Million USD	-2.57%
2020 Q2	258.4 Million USD	-14.83%
2019 Q2	317.7 Million USD	-0.16%
2019 FY	1.23 Billion USD	-5.2%
2019 Q3	288.3 Million USD	-9.25%
2019 Q1	318.2 Million USD	-10.27%
2019 Q4	311.4 Million USD	8.01%
2018 Q3	299.5 Million USD	-7.1%
2018 Q1	326.9 Million USD	0.0%
2018 Q2	322.4 Million USD	-1.38%
2018 Q4	354.6 Million USD	18.4%
2018 FY	1.3 Billion USD	5.57%
2017 FY	1.23 Billion USD	3.03%
2016 FY	1.19 Billion USD	0.0%

Peer Operating Expenses Comparison of Envista Holdings Corp

Name	Operating Expenses	Operating Expenses Difference
Alcon Inc.	4.2 Billion USD	72.654%
AptarGroup, Inc.	814.37 Million USD	-41.298%
Baxter International Inc.	5.27 Billion USD	78.173%
Becton, Dickinson and Company	6.04 Billion USD	80.971%
Bausch + Lomb Corporation	2.37 Billion USD	51.529%
Haemonetics Corporation	526.66 Million USD	-118.488%
ResMed Inc.	1.36 Billion USD	15.907%
Teleflex Incorporated	1.08 Billion USD	-6.132%
Warby Parker Inc.	437.22 Million USD	-163.186%
West Pharmaceutical Services, Inc.	454 Million USD	-153.458%